Form 4: Precision BioSciences Director Geno Germano Increases Stake in DTIL
SEC Form 4 Filing
Director Geno Germano purchased 3,250 shares of Precision BioSciences (DTIL) at $5.30 per share, increasing his total holdings.
Summary
- On March 25, 2025, Geno Germano, a director of Precision BioSciences Inc. (DTIL), acquired 3,250 shares of common stock at a price of $5.30 per share.
- Following this transaction, Germano directly owns 11,057 shares of DTIL.
- The transaction was reported on March 27, 2025.
Sentiment
Score: 6
Explanation: Insider buying is generally viewed as a positive sign, suggesting confidence in the company's prospects, but the purchase is relatively small.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors seeking to gauge management's sentiment and confidence in the company's performance.
Stakeholder Impact
- The purchase could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/25/2025 | Date of transaction: Purchase of 3,250 shares of DTIL. |
| 03/27/2025 | Date of Form 4 filing. |
Keywords
Precision BioSciences, DTIL, Geno Germano, Director, Stock Purchase, Form 4, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.